Jump to main content
Jump to site search

Issue 11, 2014
Previous Article Next Article

Platinoid complexes to target monomeric disordered peptides: a forthcoming solution against amyloid diseases?

Author affiliations

Abstract

In the present Frontier article, we highlight recent new results on the use of platinoid complexes as therapeutic agents against Alzheimer's disease and infer the relevance of targeting monomeric soluble disordered amyloid peptides to preclude the deleterious aggregation process associated with the etiology of the disease.

Graphical abstract: Platinoid complexes to target monomeric disordered peptides: a forthcoming solution against amyloid diseases?

Back to tab navigation

Supplementary files

Publication details

The article was received on 19 Oct 2013, accepted on 28 Jan 2014 and first published on 03 Feb 2014


Article type: Frontier
DOI: 10.1039/C3DT52954A
Citation: Dalton Trans., 2014,43, 4233-4237
  •   Request permissions

    Platinoid complexes to target monomeric disordered peptides: a forthcoming solution against amyloid diseases?

    C. Hureau and P. Faller, Dalton Trans., 2014, 43, 4233
    DOI: 10.1039/C3DT52954A

Search articles by author

Spotlight

Advertisements